Clinical Trial: New investigational dosage of approved medication for urinary incontinence - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: New investigational dosage of approved medication for urinary incontinence

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: To improve bladder function
Number of Subjects: 184
Location: AL|CA|CT|FL|IL|IN|IA|LA|MD|MN|NY|TN|TX|VA|WA
Contact Information
http://www.dignity2study.com/

Funding:

Allergan, Inc.

Description

A double blind, placebo controlled, parallel assignment study to evaluate the safety and effectiveness of new investigational dosage of approved medication, which is injected into the bladder muscle to treat urinary incontinence in people with MS.

Share